help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meistrich, M. L.
Right arrow Articles by Huhtaniemi, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meistrich, M. L.
Right arrow Articles by Huhtaniemi, I.

Endocrinology, Vol 137, 3823-3831, Copyright © 1996 by Endocrine Society

ARTICLES

Relationship among hormonal treatments, suppression of spermatogenesis, and testicular protection from chemotherapy-induced damage

ML Meistrich, G Wilson, WS Ye, C Thrash and I Huhtaniemi
Department of Experimental Radiotherapy, University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.

To further elucidate the mechanism by which hormonal pretreatment protects the rat testis from damage by procarbazine, we investigated the relationship between the suppression of hormone levels and spermatogenesis and the recovery of spermatogenesis from stem spermatogonia. LBNF1 rats were implanted with capsules containing testosterone or testosterone plus estradiol. After hormone treatment, rats were injected with procarbazine, and recovery of spermatogenesis was assessed. Testosterone (2 cm) plus estradiol (0.5-cm) reduced serum LH levels causing intratesticular testosterone (ITT) to fall to 3% of control levels within 2 weeks, but testis weights and sperm head counts were not appreciably suppressed until 4 weeks. Two weeks' hormone pretreatment, only slightly enhanced spermatogenesis recovery, but 4 weeks markedly increased it. Testosterone (2 cm) alone produced slower suppression of spermatogenesis and less protection from procarbazine than did testosterone plus estradiol implants, despite equivalent suppression of LH and ITT. Long testosterone implants (24-cm) partially maintained ITT at 14% of control despite undetectable LH levels, prevented any decline in sperm counts, and nearly completely abrogated the protective effect of the hormone treatment. Protection appeared to be best correlated with the testis weight reduction by hormone treatment. Thus, recovery of spermatogenesis after chemotherapy is dependent on the degree of suppression of spermatogenesis caused by the reduction of ITT levels at the time of chemotherapy and likely involves cells, such as the Sertoli cells, that are both androgen-responsive and affected by the numbers of germ cells present.


This article has been cited by other articles:


Home page
 EndocrinologyHome page
K. L. Porter, G. Shetty, and M. L. Meistrich
Testicular Edema Is Associated with Spermatogonial Arrest in Irradiated Rats
Endocrinology, March 1, 2006; 147(3): 1297 - 1305.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
G. Shetty, C. C. Y. Weng, O. U. Bolden-Tiller, I. Huhtaniemi, D. J. Handelsman, and M. L. Meistrich
Effects of Medroxyprogesterone and Estradiol on the Recovery of Spermatogenesis in Irradiated Rats
Endocrinology, October 1, 2004; 145(10): 4461 - 4469.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
Z. Zhang, M. B. Renfree, and R. V. Short
Successful Intra- and Interspecific Male Germ Cell Transplantation in the Rat
Biol Reprod, March 1, 2003; 68(3): 961 - 967.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
G. Shetty, G. Wilson, M. P. Hardy, E. Niu, I. Huhtaniemi, and M. L. Meistrich
Inhibition of Recovery of Spermatogenesis in Irradiated Rats by Different Androgens
Endocrinology, September 1, 2002; 143(9): 3385 - 3396.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. L. Meistrich, G. Wilson, and I. Huhtaniemi
Hormonal Treatment after Cytotoxic Therapy Stimulates Recovery of Spermatogenesis
Cancer Res., August 1, 1999; 59(15): 3557 - 3560.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
H. F. S. Huang, M.-T. Li, W. Giglio, R. Anesetti, J. E. Ottenweller, and L. M. Pogach
The Detrimental Effects of Spinal Cord Injury on Spermatogenesis in the Rat Is Partially Reversed by Testosterone, but Enhanced by Follicle- Stimulating Hormone
Endocrinology, March 1, 1999; 140(3): 1349 - 1355.
[Abstract] [Full Text]

Home page
 Biol. Reprod.Home page
H. F.S. Huang, M.-t. Li, R. Anesetti, W. Giglio, J. E. Ottenweller, and L. M. Pogach
Effects of Spinal Cord Injury on Spermatogenesis and the Expression of Messenger Ribonucleic Acid for Sertoli Cell Proteins in Rat Sertoli Cell-Enriched Testes
Biol Reprod, March 1, 1999; 60(3): 635 - 641.
[Abstract] [Full Text]

Home page
 Hum ReprodHome page
S. Schlatt, G. Rosiepen, G.F. Weinbauer, C. Rolf, P.F. Brook, and E. Nieschlag
Germ cell transfer into rat, bovine, monkey and human testes
Hum. Reprod., January 1, 1999; 14(1): 144 - 150.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. T. Blanchard, J. Lee, and K. Boekelheide
Leuprolide, a Gonadotropin-Releasing Hormone Agonist, Reestablishes Spermatogenesis After 2,5-Hexanedione-Induced Irreversible Testicular Injury in the Rat, Resulting in Normalized Stem Cell Factor Expression
Endocrinology, January 1, 1998; 139(1): 236 - 244.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society